Gilad Oren
Insider CIK 1929300 · APRE President/CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2026-03-12 | 2026-03-16 | 80,700 | — | $0 | 80,700 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2026-03-12 | 2026-03-16 | 20,175 | — | $0 | 393,895 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy deriv | 2026-01-30 | 2026-02-02 | 28,100 | — | $0 | 28,100 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2026-01-30 | 2026-02-02 | 28,100 | $0.89 | $25.0K | 373,720 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy deriv | 2025-12-10 | 2025-12-11 | 21,459 | $1.17 | $25.1K | 21,459 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy deriv | 2025-12-10 | 2025-12-11 | 21,459 | — | $0 | 21,459 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2025-04-03 | 2025-04-04 | 3,003 | $1.87 | $5.6K | 343,123 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2025-04-03 | 2025-04-04 | 2,497 | $1.80 | $4.5K | 345,620 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2025-03-27 | 2025-03-31 | 26,900 | — | $0 | 26,900 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2025-03-27 | 2025-03-31 | 6,725 | — | $0 | 340,120 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2024-10-23 | 2024-10-24 | 500 | $3.92 | $2.0K | 333,395 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2024-10-15 | 2024-10-16 | 250 | $2.90 | $725 | 332,895 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2024-10-14 | 2024-10-15 | 1,000 | $2.59 | $2.6K | 332,645 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2024-10-10 | 2024-10-15 | 150 | $2.54 | $381 | 331,645 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2024-03-28 | 2024-03-28 | 26,900 | — | $0 | 26,900 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2024-03-28 | 2024-03-28 | 6,725 | — | $0 | 331,495 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy deriv | 2024-03-13 | 2024-03-14 | 1,000 | — | $0 | 1,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy deriv | 2024-03-13 | 2024-03-14 | 1,000 | — | $0 | 1,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2024-03-13 | 2024-03-14 | 2,000 | $7.29 | $14.6K | 324,770 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2023-03-09 | 2023-03-13 | 16,000 | — | $0 | 16,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2023-03-09 | 2023-03-13 | 4,000 | — | $0 | 322,770 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion deriv | 2022-08-23 | 2023-03-13 | 604,510 | — | $0 | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion | 2022-08-23 | 2023-03-13 | 6,045,100 | — | $0 | 6,375,414 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2022-07-28 | 2022-08-01 | 148,700 | — | $0 | 148,700 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2022-07-28 | 2022-08-01 | 101,300 | — | $0 | 330,314 | SEC↗ |